EUVIMEDEUVIMED entdecken
Crossref

Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin models

Dilem Ceren Apaydin, Gaurav Sadhnani, Tiffany Carlaw, Jan Renziehausen, Elena Lizunova, Viviane Filor, Anna Hiller, Sophia Brumhard, Vincent Halim, Ulrike Brüning, Johannes Bischof, Rafaela Horbach Marodin und 13 weitere

Cell Stem Cell · 2026-02 · 33 (2) · 233-252.e12

DOI: 10.1016/j.stem.2026.01.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2026-02. Verfasst von Dilem Ceren Apaydin und 24 weiteren Autor:innen. Beteiligte Einrichtung: Berlin Institute of Health, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Be…. Hauptthemen laut MEDLINE: Nanoparticles, Skin, Mutation, Gene Editing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 124 Literaturangaben. Gefördert von: Horizon 2020 Framework Programme, Bundesministerium für Forschung, Technologie und Raumfahrt, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autosomal recessive congenital ichthyosis (ARCI) refers to a group of rare, highly debilitating skin disorders that significantly impair patients' quality of life and lack any effective treatment options. Here, we report clinically relevant in situ correction of the most common ARCI-causing mutation, TGM1 c.877-2A>G, a splice-site aberration, in human disease models. Targeted skin barrier modulation followed by topical application of the cytosine base editor eTd packaged into lipid nanoparticles yielded functional restoration of ∼30% of wild-type transglutaminase 1 activity in skin tissue. Toxicity studies and comprehensive off-target analysis demonstrated an excellent safety profile even after repeated application, without systemic distribution of the lipid nanoparticles or the genetic cargo as determined via highly sensitive methods, including desorption electrospray ionization (DESI) metabolic imaging. This study presents comprehensive preclinical data on the feasibility of in situ gene correction of genodermatoses-causing mutations, showcasing its therapeutic potential and paving the way for curative next-generation treatments for severe genetic skin diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesSkinMutationGene EditingLipidsHumansAnimalsTransglutaminasesMiceFemaleGenetic TherapyGene Therapy AgentsLiposomes

Stichwörter der Autor:innen

ARCIautosomal recessive congenital ichthyosiscytosine base editorfunctional rescuegene therapygenomic safetyin situ gene editingin vivo gene therapylipid nanoparticlestransglutaminase 1

Substanzen

LipidsTransglutaminasestransglutaminase 1Lipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Berlin Institute of Health, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin 10117, Germany.
  • School of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Institute for Pharmacology and Toxicology, School of Veterinary Medicine, Freie Universität Berlin, Berlin 14195, Germany.
  • Department of Biochemistry & Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, Salzburg 5020, Austria.
  • NanoVation Therapeutics, Vancouver, BC V6T 1Z3, Canada.

Förderung

  • Horizon 2020 Framework Programme
  • Bundesministerium für Forschung, Technologie und Raumfahrt
  • Canadian Institutes of Health Research
  • Dystrophic Epidermolysis Bullosa Research Association of America
  • European Research Council
  • Berlin Institute of Health
  • LEO Fondet
  • Canada Research Chairs

Zitieren

APA

Apaydin, D. C., Sadhnani, G., Carlaw, T., Renziehausen, J., Lizunova, E., Filor, V., Hiller, A., Brumhard, S., Halim, V., Brüning, U., Bischof, J., Marodin, R. H., Kurek, D. Z., Rhiel, M., Ammann, S., Cornu, T. I., Cathomen, T., Sander, L. E., Obermayer, B., …, & Hedtrich, S. (2026). Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin models. Cell Stem Cell, 33(2), 233-252.e12. https://doi.org/10.1016/j.stem.2026.01.001

Vancouver

Apaydin DC, Sadhnani G, Carlaw T, Renziehausen J, Lizunova E, Filor V, et al. Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin models. Cell Stem Cell. 2026;33(2):233-252.e12. doi:10.1016/j.stem.2026.01.001

BibTeX
@article{Apaydin2026,
  author = {Apaydin, Dilem Ceren and Sadhnani, Gaurav and Carlaw, Tiffany and Renziehausen, Jan and Lizunova, Elena and Filor, Viviane and Hiller, Anna and Brumhard, Sophia and Halim, Vincent and Brüning, Ulrike and Bischof, Johannes and Marodin, Rafaela Horbach and Kurek, Daniel Z and Rhiel, Manuel and Ammann, Sandra and Cornu, Tatjana I and Cathomen, Toni and Sander, Leif Erik and Obermayer, Benedikt and Coscia, Fabian and Kirwan, Jennifer and Koller, Ulrich and Gruber, Achim D and Bäumer, Wolfgang and Hedtrich, Sarah},
  title = {Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin models},
  journal = {Cell Stem Cell},
  year = {2026},
  volume = {33},
  number = {2},
  pages = {233--252.e12},
  doi = {10.1016/j.stem.2026.01.001}
}
Kostenlos starten →